What does this company do and how does it make money?

Atlassian operates a classic software-as-a-service model where nearly all revenue comes from recurring licenses and services. The extreme concentration in one revenue line (94.5%) combined with 300,000+ customers creates both platform dependency and pricing power — evidenced by the 0.988 correlation between revenue and inflation.

Five legendary investment frameworks analyzed this company.

Mauboussin sees the 'widest expectations gap' he's encountered while Marks spots a classic cycle peak — both staring at the same 20-quarter insider selling streak that's seen executives dump $211 million in stock. Tap any framework below to see their complete analysis and position.

How much cash does it generate and where does it go?

The company generates substantial cash ($1.27B FCF) but spends it even faster — R&D alone consumes 4.6x operating cash flow while buybacks take another 1.1x. The 28.5% stock compensation rate means nearly a third of every revenue dollar goes to employee equity, making this less a cash machine than a growth-at-any-cost operation.

Is the business getting stronger or weaker?

The business shows conflicting signals — revenue growth remains robust at 20.1% and gross margins near historical highs prove pricing power, but the company hasn't been operationally profitable since Q4'19. The gradual improvement from -17.6% to -3.1% operating margin suggests management is trying to balance growth with profitability, but hasn't succeeded yet.

What could go wrong and has it survived trouble before?

The biggest risk signal is behavioral — insiders have sold shares for 20 straight quarters while the stock fell 85% from its peak. The market's asymmetric reaction to earnings (severe punishment for misses, no reward for beats) suggests investors expect perfection. Despite the 'A' resilience grade, the company's extreme revenue concentration and insider exodus point to execution risks the market hasn't fully processed.

When insiders sell for 20 consecutive quarters while revenue hits $1.59B at the 98th percentile, those running the company see something the growth metrics don't capture.

Is the stock priced for perfection, fair value, or pessimism?

The market has given up on growth, pricing in just 1.36% perpetual expansion for a company growing FCF at 20.1%. The DCF suggests 33% upside exists if the company can maintain its cash generation, but with negative earnings yield versus 4.33% treasuries, investors are literally paying for the privilege of owning losses. The wide analyst target range ($100-$290) reflects fundamental disagreement about the company's trajectory.